Abstract
The aim of this study was to evaluate phagocytic and oxidative activities of monocytes and granulocytes during combined therapy of mice infected by drug-resistant Staphylococcus aureus SCAID OTT1-2022. The treatment of the infected mice was conducted by using an iodine-containing coordination compound CC-195, antibiotic cefazolin and by a combined therapy with CC-195 and cefazolin. The PHAGOTEST and BURSTTEST kits (BD Biosciences, USA) were used to determine the phagocytic and oxidative activities. The samples were analyzed on a FACSCalibur flow cytometer (BD Biosciences, United States). It was found that the different treatment regiments applied on the infected animals caused a statistically significant differentiation in numbers and activity of monocytes and granulocytes in comparison to the negative and positive control animals (intact and infected but untreated mice, respectively).